Busilvex Solution

    Busilvex Solution

    S4

    API: Busulfan | Company: Pierre-Fabre

    1. What BUSILVEX is and what it is used for.

    BUSILVEX is used in adults as a treatment prior to transplantation in combination with cyclophosphamide. You will receive this preparative medicine before receiving a transplant of either bone marrow or haematopoietic progenitor cell.

    2. What you need to know before you take/use BUSILVEX.

    Do not use BUSILVEX:

    • if you are hypersensitive to busulfan or any of the other ingredients
    • if you are pregnant or think you are pregnant
    • if you suffer from hepatic insufficiency
    • there is no experience of use of BUSILVEX in children

    Take special care with BUSILVEX:

    BUSILVEX is a potent cytotoxic drug that results in profound decrease of blood cells. At the recommended dose, this is the desired effect. Therefore, careful monitoring will be performed. It is possible that the use of BUSILVEX may increase the risk of suffering another malignancy in the future.

    You should tell your doctor if:

    • You have a liver, kidney, heart or lung problem
    • You have a history of seizures
    • You are currently taking other medicines

    If you are pregnant or breast feeding your baby while taking this medicine please consult your doctor, pharmacist or other health care professional for advice.

    If you are taking medicines on a regular basis, concomitant use of medicine may cause undesirable interactions. Please consult your doctor, pharmacist or other health care professional for advice.

    Particular caution should be taken if you use itraconazole (used for certain types of infections) or ketobemidone (used to treat pain) because this may increase the side-effects. Paracetamol should be used with caution during the 72 hours prior to or with BUSILVEX administration.

    3. How to take/use BUSILVEX.

    The dose will be calculated according to your body weight. The recommended dose is 0,8 mg/kg of body weight in adult patients. In combination with cyclophosphamide.

    BUSILVEX is administered by a qualified health care professional as a central intravenous infusion, after dilution of the individual ampoule. Each infusion will last 2 hours. BUSILVEX will be administered every 6 hours during 4 consecutive days prior to transplant.

    Before receiving BUSILVEX you will be medicated with:

    • anticonvulsive agents to prevent seizures
    • antiemetic agents to prevent vomiting

    Do not share medicines prescribed for you with others. In the event of overdosage consult your doctor or pharmacist. If neither is available, rush the patient to the nearest hospital or poison control centre.

    4. Possible side effects.

    Serious side-effects:

    The most serious side-effects of BUSILVEX therapy or the transplant procedure may include decrease in circulating blood cell counts (intended effect of the drug to prepare you for your transplant infusion). Infection, liver disorders including blocking of a liver vein, graft versus host disease (the graft attacks your body) and lung complications. Your doctor will monitor your blood counts and liver enzymes regularly to detect and manage these events.

    Very common side-effects (reported in more than 1 patient out of 10):

    Blood: decrease of blood circulating cells (red and white) and platelets.

    Nervous system: insomnia, anxiety, dizziness and depression.

    Nutrition: decrease in magnesium, calcium, potassium phosphate in blood and increase in blood sugar.

    Cardiac: increase in heart rate, increase or decrease of blood pressure, vasodilation and blood clots.

    Respiratory: shortness of breath, nasal secretion, sore throat, cough, hiccup, nosebleeds, abnormal breath sounds.

    Gastro-intestinal: Nausea, inflammation of the mucosa of the mouth, vomiting, loss of appetite, diarrhoea, constipation, heart burn, anus discomfort.

    Hepatic: jaundice, elevate liver enzymes.

    Skin: rash, itching, loss of hairs.

    Muscle and bone: back, muscle and joint pain.

    Renal: increase in creatinine elimination, discomfort in urination and decrease in urine output.

    General: weight increase, fever, headache, abdominal pain, weakness, chills, pain, allergic reaction, oedema, general pain and inflammation at the injection site, chest pain.

    Common side-effects (reported in 1 to 10 patients out of 100):

    Nervous system: confusion

    Nutrition: low blood sodium

    Cardiac: changes and abnormalities in heart rhythm, fluid retention or inflammation around the heart, decreased heart output.

    Respiratory: increase in breath rhythm, respiratory failure, alveolar bleeding, asthma, collapse of small portions the lung, fluid around the lung.

    Gastro-intestinal: inflammation of the mucosa of oesophagus, paralysis of the gut, Vomiting blood.

    Hepatic: enlarged liver.

    Renal: increase in amounts of nitrogen in the blood stream, blood in the urine, moderate renal insufficiency.

    Uncommon side-effects (reported in 1 to 10 patients out of 1000):

    Nervous system: delirium nervousness, hallucination, agitation, abnormal brain function, cerebral haemorrhage and seizure.

    Cardiac: clotting of femoral artery, thrombosis, extra heart beats, decrease in heart rate, diffuse leak of fluid from the capillaries (small blood vessels).

    Respiratory: decrease in blood oxygen.

    Gastro-intestinal: bleeding in the stomach or gut.

    Not all side-effects reported for this medicine are included in this leaflet. Should your general health worsen while taking this medicine, please consult your doctor, pharmacist or other health care professional for advice.

    5. How to store BUSILVEX.

    KEEP ALL MEDICINES OUT OF REACH OF CHILDREN

    Store between + 2 °C and + 8 °C (in refrigerator) in the closed original packaging. Do not freeze

    Important Disclaimer

    The Busilvex Solution professional information leaflet below is the property of Pierre-Fabre and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Busilvex Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites